Key statistics
As of last trade, Alto Neuroscience Inc (ANRO:NYQ) traded at 4.42, 22.44% above the 52 week low of 3.61 set on Nov 05, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 4.39 |
---|---|
High | 4.46 |
Low | 4.33 |
Bid | 4.41 |
Offer | 4.43 |
Previous close | 4.31 |
Average volume | 406.99k |
---|---|
Shares outstanding | 26.96m |
Free float | 24.93m |
P/E (TTM) | -- |
Market cap | 116.19m USD |
EPS (TTM) | -2.42 USD |
Data delayed at least 15 minutes, as of Nov 25 2024 15:38 GMT.
More ▼
- Alto Neuroscience Reports Third Quarter 2024 Financial Results and Recent Business Highlights
- Alto Neuroscience to Participate in Upcoming Investor Conferences
- Alto Neuroscience Reports Topline Results from a Phase 2b Trial Evaluating ALTO-100 as a Treatment for Major Depressive Disorder
- Alto Neuroscience Announces Peer-Reviewed Publication in the Journal of Clinical Psychiatry Demonstrating Baseline Cognitive Performance is Not a Moderator of Response to Standard-of-Care Antidepressants